[…]
Interaction of environment, genetics and autoimmunity in the pathogenesis of rheumatoid arthritis (RA)
[…]
Rituximab Receives FDA Approval for Treatment of RA
[…]
Sleep Disturbance is Increased in Rheumatoid Arthritis
[…]
Subcutaneous vs. Oral Methotrexate : Which is Preferred in Rheumatoid Arthritis?
Oral vs. subcutaneous (sq) administration of methotrexate is generally considered equivalent in rheumatoid arthritis (RA) treatment. However, the enhanced bioavailability of sq methotrexate may make this route of administration preferable to the oral route in certain patients.
Risedronate not an Effective Disease Modifier in Knee Osteoarthritis
Despite its prevalence, no effective pharmacotherapies have been definitively proven to modify the course of radiographic knee osteoarthritis (OA). Risedronate, a bisphosphonate that reduces bone turnover, has been shown in animal models to inhibit cartilage degradation and progression of disease.
